Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · September 15, 2022

Serum Fibrosis Tests Guide Prognosis in Patients With MAFLD Referred From Primary Care

Clinical Gastroenterology and Hepatology


Additional Info

Clinical Gastroenterology and Hepatology
Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction-Associated Fatty Liver Disease Patients Referred From Primary Care
Clin. Gastroenterol. Hepatol. 2022 Sep 01;20(9)2041-2049.e5, Z Wang, LC Bertot, GP Jeffrey, J Joseph, G Garas, B de Boer, Y Huang, G MacQuillan, M Wallace, B Smith, LA Adams

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading